Fermion’s CDMO API services cover the needs of a customer from Phase I clinical studies until commercial production. We have extensive experience in NCE drug substance development and manufacturing since 1990’s. Currently there are about 10 originally new chemical entities wherein Fermion has had an important role during the development of the drug substance. These molecules are sold on the global market including USA, EU, Japan and China.

To secure timely completion of each critical phase of customer’s NCE project, we follow a carefully designed process with milestones and deliverables set for Phase I, II, and III, and for moving to commercial phase.